No need for antimetabolites?

Article

No need for antimetabolites?

Combined phacoemulsification and trabeculectomy with releasable sutures can be performed safely and effectively in the absence of antimetabolites, according to a study published in the February 2006 issue of the British Journal of Ophthalmology.

The analysis of 251 eyes of 198 patients after a combined phaco/trabeculectomy procedure was carried out by Walter J. Stark, MD and colleagues of Wilmer Eye Institute, John Hopkins University, Baltimore, USA.Patients were followed up for, on average, 16 months and were evaluated for vision, intraocular pressure (IOP) and a series of glaucoma medications.

The investigators noted a mean postoperative decrease of 19.2% for IOP and 84.1% for a number of glaucoma medications; 85% of eyes required fewer glaucoma medications and 78% of eyes were medication free, with IOP control.

The authors concluded that the procedure is a safe, effective and stable alternative for patients with cataracts and glaucoma in the absence of antimetabolites.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
© 2025 MJH Life Sciences

All rights reserved.